Saumya E. Samaraweera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saumya E. Samaraweera has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Richard J. D'ANdrea
Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia
71 shared publications - Brooks A. Benard
Stanford University
66 shared publications - Daniel Thomas
School of Medicine, College of Health, Adelaide University, Adelaide, Australia
66 shared publications - Angel F. Lopez
Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia
65 shared publications - Andy G. X. Zeng
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
64 shared publications - C. Glenn Begley
11Begley Biotech Consulting, Wallington, Victoria, Australia
64 shared publications
Latest Publications
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
IL3Rα P248 at the IL-3R assembly interface is critical for cell differentiation.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
IL3Rα P248 at the IL-3R assembly interface is critical for cell differentiation.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Summary of the key interactions in the IL-3R ternary complex in the IL-3R ternary complex crystal structure.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Summary of the key interactions in the IL-3R ternary complex in the IL-3R ternary complex crystal structure.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
The IL-3R dodecamer activates STAT1 to induce cell differentiation.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
The IL-3R dodecamer activates STAT1 to induce cell differentiation.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Key interactions between distinct residues in the IL-3R ternary complex crystal structure.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Key interactions between distinct residues in the IL-3R ternary complex crystal structure.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Enrichment of the IL-3R hexamer versus dodecamer gene signature in primitive normal and leukemic stem cells.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Enrichment of the IL-3R hexamer versus dodecamer gene signature in primitive normal and leukemic stem cells.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Data collection and refinement statistics for the IL-3R ternary complex crystal structure.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Data collection and refinement statistics for the IL-3R ternary complex crystal structure.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
IL3Rα/βc transcript and protein expression ratio in AML patient samples.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
IL3Rα/βc transcript and protein expression ratio in AML patient samples.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Increasing IL3Rα/βc ratios lead to hexameric receptor assembly and augmented quiescence.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Increasing IL3Rα/βc ratios lead to hexameric receptor assembly and augmented quiescence.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Increasing IL3Rα/βc ratios and enforced hexamer signaling lead to reduced differentiation in in vivo engraftments.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
Increasing IL3Rα/βc ratios and enforced hexamer signaling lead to reduced differentiation in in vivo engraftments.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from Distinct assemblies of heterodimeric cytokine receptors govern stemness programs in leukemia
IL3Rα/βc transcript and protein expression ratio in AML patient samples.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Distinct assemblies of heterodimeric cytokine receptors govern stemness programs in leukemia
IL3Rα/βc transcript and protein expression ratio in AML patient samples.